Clinical Trial Update: Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing gemcitabine alone versus gemcitabine plus CI-994 in patients with advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CI-994
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Pfizer | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED